• Je něco špatně v tomto záznamu ?

Cholinergic white matter pathways along the Alzheimer's disease continuum

M. Nemy, M. Dyrba, F. Brosseron, K. Buerger, P. Dechent, L. Dobisch, M. Ewers, K. Fliessbach, W. Glanz, D. Goerss, MT. Heneka, S. Hetzer, EI. Incesoy, D. Janowitz, I. Kilimann, C. Laske, F. Maier, MH. Munk, R. Perneczky, O. Peters, L. Preis, J....

. 2023 ; 146 (5) : 2075-2088. [pub] 2023May02

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011506

Previous studies have shown that the cholinergic nucleus basalis of Meynert and its white matter projections are affected in Alzheimer's disease dementia and mild cognitive impairment. However, it is still unknown whether these alterations can be found in individuals with subjective cognitive decline, and whether they are more pronounced than changes found in conventional brain volumetric measurements. To address these questions, we investigated microstructural alterations of two major cholinergic pathways in individuals along the Alzheimer's disease continuum using an in vivo model of the human cholinergic system based on neuroimaging. We included 402 participants (52 Alzheimer's disease, 66 mild cognitive impairment, 172 subjective cognitive decline and 112 healthy controls) from the Deutsches Zentrum für Neurodegenerative Erkrankungen Longitudinal Cognitive Impairment and Dementia Study. We modelled the cholinergic white matter pathways with an enhanced diffusion neuroimaging pipeline that included probabilistic fibre-tracking methods and prior anatomical knowledge. The integrity of the cholinergic white matter pathways was compared between stages of the Alzheimer's disease continuum, in the whole cohort and in a CSF amyloid-beta stratified subsample. The discriminative power of the integrity of the pathways was compared to the conventional volumetric measures of hippocampus and nucleus basalis of Meynert, using a receiver operating characteristics analysis. A multivariate model was used to investigate the role of these pathways in relation to cognitive performance. We found that the integrity of the cholinergic white matter pathways was significantly reduced in all stages of the Alzheimer's disease continuum, including individuals with subjective cognitive decline. The differences involved posterior cholinergic white matter in the subjective cognitive decline stage and extended to anterior frontal white matter in mild cognitive impairment and Alzheimer's disease dementia stages. Both cholinergic pathways and conventional volumetric measures showed higher predictive power in the more advanced stages of the disease, i.e. mild cognitive impairment and Alzheimer's disease dementia. In contrast, the integrity of cholinergic pathways was more informative in distinguishing subjective cognitive decline from healthy controls, as compared with the volumetric measures. The multivariate model revealed a moderate contribution of the cholinergic white matter pathways but not of volumetric measures towards memory tests in the subjective cognitive decline and mild cognitive impairment stages. In conclusion, we demonstrated that cholinergic white matter pathways are altered already in subjective cognitive decline individuals, preceding the more widespread alterations found in mild cognitive impairment and Alzheimer's disease. The integrity of the cholinergic pathways identified the early stages of Alzheimer's disease better than conventional volumetric measures such as hippocampal volume or volume of cholinergic nucleus basalis of Meynert.

Ageing Epidemiology Research Unit School of Public Health Imperial College London London UK

Berlin Center for Advanced Neuroimaging Charité Universitätsmedizin Berlin Berlin Germany

Centre for Clinical Brain Sciences University of Edinburgh and UK DRI Edinburgh UK

Department for Biomedical Magnetic Resonance University of Tübingen Tübingen Germany

Department for Neurodegenerative Diseases and Geriatric Psychiatry University Hospital Bonn Bonn Germany

Department of Biomedical Engineering and Assistive Technology Czech Institute of Informatics Robotics and Cybernetics Czech Technical University Prague Prague Czech Republic

Department of Cybernetics Faculty of Electrical Engineering Czech Technical University Prague Prague Czech Republic

Department of Neuroimaging Centre for Neuroimaging Science Institute of Psychiatry Psychology and Neuroscience King's College London London UK

Department of Neurology University of Bonn Bonn Germany

Department of Psychiatry and Psychotherapy Charité Berlin Germany

Department of Psychiatry and Psychotherapy School of Medicine Technical University of Munich Munich Germany

Department of Psychiatry and Psychotherapy University Hospital LMU Munich Munich Germany

Department of Psychiatry and Psychotherapy University Medical Center Goettingen University of Goettingen Goettingen Germany

Department of Psychiatry Charité Universitätsmedizin Berlin Campus Benjamin Franklin Berlin Germany

Department of Psychiatry Medical Faculty University of Cologne Cologne Germany

Department of Psychosomatic Medicine Rostock University Medical Center Rostock Germany

Division of Clinical Geriatrics Center for Alzheimer Research Department of Neurobiology Care Sciences and Society Karolinska Institute Stockholm Sweden

Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases University of Cologne Cologne Germany

German Center for Neurodegenerative Diseases Berlin Germany

German Center for Neurodegenerative Diseases Bonn Germany

German Center for Neurodegenerative Diseases Goettingen Germany

German Center for Neurodegenerative Diseases Magdeburg Germany

German Center for Neurodegenerative Diseases Munich Germany

German Center for Neurodegenerative Diseases Rostock Germany

German Center for Neurodegenerative Diseases Tübingen Germany

Institute for Stroke and Dementia Research University Hospital LMU Munich Munich Germany

Institute of Cognitive Neurology and Dementia Research Otto von Guericke University Magdeburg Germany

Leibniz Institute for Neurobiology Magdeburg Germany

MR Research in Neurosciences Department of Cognitive Neurology Georg August University Goettingen Goettingen Germany

Munich Cluster for Systems Neurology Munich Germany

Neurosciences and Signaling Group Institute of Biomedicine Department of Medical Sciences University of Aveiro Aveiro Portugal

Section for Dementia Research Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy University of Tübingen Tübingen Germany

Sheffield Institute for Translational Neurosciences University of Sheffield Sheffield UK

Theme Inflammation and Aging Karolinska University Hospital Stockholm Sweden

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011506
003      
CZ-PrNML
005      
20230801133108.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/brain/awac385 $2 doi
035    __
$a (PubMed)36288546
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Nemy, Milan $u Department of Cybernetics, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic $u Department of Biomedical Engineering and Assistive Technology, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University in Prague, Prague, Czech Republic $u Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden $1 https://orcid.org/0000000248701354
245    10
$a Cholinergic white matter pathways along the Alzheimer's disease continuum / $c M. Nemy, M. Dyrba, F. Brosseron, K. Buerger, P. Dechent, L. Dobisch, M. Ewers, K. Fliessbach, W. Glanz, D. Goerss, MT. Heneka, S. Hetzer, EI. Incesoy, D. Janowitz, I. Kilimann, C. Laske, F. Maier, MH. Munk, R. Perneczky, O. Peters, L. Preis, J. Priller, BS. Rauchmann, S. Röske, N. Roy, K. Scheffler, A. Schneider, BH. Schott, A. Spottke, EJ. Spruth, M. Wagner, J. Wiltfang, R. Yakupov, M. Eriksdotter, E. Westman, O. Stepankova, L. Vyslouzilova, E. Düzel, F. Jessen, SJ. Teipel, D. Ferreira
520    9_
$a Previous studies have shown that the cholinergic nucleus basalis of Meynert and its white matter projections are affected in Alzheimer's disease dementia and mild cognitive impairment. However, it is still unknown whether these alterations can be found in individuals with subjective cognitive decline, and whether they are more pronounced than changes found in conventional brain volumetric measurements. To address these questions, we investigated microstructural alterations of two major cholinergic pathways in individuals along the Alzheimer's disease continuum using an in vivo model of the human cholinergic system based on neuroimaging. We included 402 participants (52 Alzheimer's disease, 66 mild cognitive impairment, 172 subjective cognitive decline and 112 healthy controls) from the Deutsches Zentrum für Neurodegenerative Erkrankungen Longitudinal Cognitive Impairment and Dementia Study. We modelled the cholinergic white matter pathways with an enhanced diffusion neuroimaging pipeline that included probabilistic fibre-tracking methods and prior anatomical knowledge. The integrity of the cholinergic white matter pathways was compared between stages of the Alzheimer's disease continuum, in the whole cohort and in a CSF amyloid-beta stratified subsample. The discriminative power of the integrity of the pathways was compared to the conventional volumetric measures of hippocampus and nucleus basalis of Meynert, using a receiver operating characteristics analysis. A multivariate model was used to investigate the role of these pathways in relation to cognitive performance. We found that the integrity of the cholinergic white matter pathways was significantly reduced in all stages of the Alzheimer's disease continuum, including individuals with subjective cognitive decline. The differences involved posterior cholinergic white matter in the subjective cognitive decline stage and extended to anterior frontal white matter in mild cognitive impairment and Alzheimer's disease dementia stages. Both cholinergic pathways and conventional volumetric measures showed higher predictive power in the more advanced stages of the disease, i.e. mild cognitive impairment and Alzheimer's disease dementia. In contrast, the integrity of cholinergic pathways was more informative in distinguishing subjective cognitive decline from healthy controls, as compared with the volumetric measures. The multivariate model revealed a moderate contribution of the cholinergic white matter pathways but not of volumetric measures towards memory tests in the subjective cognitive decline and mild cognitive impairment stages. In conclusion, we demonstrated that cholinergic white matter pathways are altered already in subjective cognitive decline individuals, preceding the more widespread alterations found in mild cognitive impairment and Alzheimer's disease. The integrity of the cholinergic pathways identified the early stages of Alzheimer's disease better than conventional volumetric measures such as hippocampal volume or volume of cholinergic nucleus basalis of Meynert.
650    _2
$a lidé $7 D006801
650    12
$a Alzheimerova nemoc $x psychologie $7 D000544
650    12
$a bílá hmota $7 D066127
650    _2
$a mozek $7 D001921
650    12
$a kognitivní dysfunkce $x psychologie $7 D060825
650    _2
$a cholinergní látky $7 D018678
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dyrba, Martin $u German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany $1 https://orcid.org/0000000233533167
700    1_
$a Brosseron, Frederic $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
700    1_
$a Buerger, Katharina $u German Center for Neurodegenerative Diseases (DZNE), Munich, Germany $u Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
700    1_
$a Dechent, Peter $u MR-Research in Neurosciences, Department of Cognitive Neurology, Georg-August-University Goettingen, Goettingen, Germany
700    1_
$a Dobisch, Laura $u German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
700    1_
$a Ewers, Michael $u German Center for Neurodegenerative Diseases (DZNE), Munich, Germany $u Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany $1 https://orcid.org/0000000152311714
700    1_
$a Fliessbach, Klaus $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany $u Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
700    1_
$a Glanz, Wenzel $u German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
700    1_
$a Goerss, Doreen $u German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany $u Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany $1 https://orcid.org/0000000253368349
700    1_
$a Heneka, Michael T $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany $u Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
700    1_
$a Hetzer, Stefan $u Berlin Center for Advanced Neuroimaging, Charité-Universitätsmedizin Berlin, Berlin, Germany
700    1_
$a Incesoy, Enise I $u German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany $u Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke University, Magdeburg, Germany
700    1_
$a Janowitz, Daniel $u Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
700    1_
$a Kilimann, Ingo $u German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany $u Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany $1 https://orcid.org/0000000232694452
700    1_
$a Laske, Christoph $u German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany $u Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany
700    1_
$a Maier, Franziska $u Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany
700    1_
$a Munk, Matthias H $u German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany $u Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany
700    1_
$a Perneczky, Robert $u German Center for Neurodegenerative Diseases (DZNE), Munich, Germany $u Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany $u Munich Cluster for Systems Neurology (SyNergy), Munich, Germany $u Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, UK $u Sheffield Institute for Translational Neurosciences (SITraN), University of Sheffield, Sheffield, UK
700    1_
$a Peters, Oliver $u German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany $u Department of Psychiatry, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
700    1_
$a Preis, Lukas $u Department of Psychiatry, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
700    1_
$a Priller, Josef $u German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany $u Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany $u Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany $u Centre for Clinical Brain Sciences, University of Edinburgh and UK DRI, Edinburgh, UK
700    1_
$a Rauchmann, Boris-Stephan $u Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
700    1_
$a Röske, Sandra $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
700    1_
$a Roy, Nina $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
700    1_
$a Scheffler, Klaus $u Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany
700    1_
$a Schneider, Anja $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany $u Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
700    1_
$a Schott, Björn H $u German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany $u Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany $u Leibniz Institute for Neurobiology, Magdeburg, Germany $1 https://orcid.org/0000000282374481
700    1_
$a Spottke, Annika $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany $u Department of Neurology, University of Bonn, Bonn, Germany
700    1_
$a Spruth, Eike J $u German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany $u Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany
700    1_
$a Wagner, Michael $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany $u Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany
700    1_
$a Wiltfang, Jens $u German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany $u Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany $u Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal
700    1_
$a Yakupov, Renat $u German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany $1 https://orcid.org/000000023868284X
700    1_
$a Eriksdotter, Maria $u Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden $u Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden $1 https://orcid.org/0000000324984000
700    1_
$a Westman, Eric $u Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden $u Department of Neuroimaging, Centre for Neuroimaging Science, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK $1 https://orcid.org/0000000231152977
700    1_
$a Stepankova, Olga $u Department of Biomedical Engineering and Assistive Technology, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000243841868 $7 mzk2004219448
700    1_
$a Vyslouzilova, Lenka $u Department of Biomedical Engineering and Assistive Technology, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000257226671 $7 xx0272308
700    1_
$a Düzel, Emrah $u German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany $u Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke University, Magdeburg, Germany $1 https://orcid.org/0000000201395388
700    1_
$a Jessen, Frank $u German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany $u Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany $u Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany $1 https://orcid.org/0000000310672102
700    1_
$a Teipel, Stefan J $u German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany $u Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany $1 https://orcid.org/0000000235863194
700    1_
$a Ferreira, Daniel $u Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden $1 https://orcid.org/0000000195224338
773    0_
$w MED00009356 $t Brain : a journal of neurology $x 1460-2156 $g Roč. 146, č. 5 (2023), s. 2075-2088
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36288546 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133105 $b ABA008
999    __
$a ok $b bmc $g 1963739 $s 1197771
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 146 $c 5 $d 2075-2088 $e 2023May02 $i 1460-2156 $m Brain $n Brain $x MED00009356
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace